Ntrk2tm1.1Lfr/Ntrk2+
involves: 129X1/SvJ
|
abnormal peripheral nervous system regeneration |
J:116954
|
Ntrk2tm1.1Tes/Ntrk2+
B6.129S1-Ntrk2tm1.1Tes
|
increased thigmotaxis |
J:144845
|
Ntrk2tm1.1Tes/Ntrk2tm1.1Tes
B6.129S1-Ntrk2tm1.1Tes
|
abnormal amygdala morphology |
J:144845
|
abnormal dendrite morphology |
J:144845
|
increased thigmotaxis |
J:144845
|
Ntrk2tm1.1Tes/Ntrk2tm1.1Tes
involves: 129S1/Sv
|
abnormal mammary gland sensory innervation pattern |
J:192549
|
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2+
C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H
|
abnormal rib morphology |
J:211773
|
decreased prepulse inhibition |
J:211773
|
increased circulating HDL cholesterol level |
J:211773
|
increased lean body mass |
J:211773
|
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2tm1b(EUCOMM)Wtsi
C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H
|
preweaning lethality, incomplete penetrance |
J:211773
|
Ntrk2tm1Bbd/Ntrk2tm1Bbd
involves: 129S2/SvPas
|
abnormal barrel cortex morphology |
J:103935
|
abnormal cerebellum development |
J:49472
|
abnormal Purkinje cell dendrite morphology |
J:49472
|
abnormal sensory neuron innervation pattern |
J:103935,
J:104489
|
abnormal somatic nervous system morphology |
J:104489
|
postnatal lethality, complete penetrance |
J:104489
|
small cochlear ganglion |
J:104489
|
small geniculate ganglion |
J:104489
|
small L4 dorsal root ganglion |
J:104489
|
small nodose ganglion |
J:49472,
J:104489
|
small petrosal ganglion |
J:104489
|
small trigeminal ganglion |
J:104489
|
small vestibular ganglion |
J:49472,
J:104489
|
Ntrk2tm1Bbd/Ntrk2tm1Bbd
involves: 129S2/SvPas * C57BL/6
|
abnormal cochlear ganglion morphology |
J:29245
|
abnormal cochlear OHC afferent innervation pattern |
J:29245
|
abnormal crista ampullaris neuroepithelium morphology |
J:29245
|
abnormal inner ear vestibular sensory neuron innervation pattern |
J:29245
|
abnormal sensory neuron innervation pattern |
J:29245
|
abnormal utricular macula morphology |
J:29245
|
abnormal vestibular ganglion morphology |
J:29245
|
abnormal vestibular nerve morphology |
J:29245
|
abnormal vibrissae reflex |
J:56847
|
absent suckling reflex |
J:56847
|
decreased motor neuron number |
J:56847
|
neonatal lethality, incomplete penetrance |
J:56847
|
no swallowing reflex |
J:56847
|
small cochlear ganglion |
J:29245
|
small dorsal root ganglion |
J:56847
|
small facial motor nucleus |
J:56847
|
small trigeminal ganglion |
J:56847
|
small vestibular ganglion |
J:29245
|
Ntrk2tm1Bbd/Ntrk2tm1Kln
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
|
abnormal cochlear OHC afferent innervation pattern |
J:84871
|
abnormal cochlear sensory epithelium morphology |
J:84871
|
abnormal inner ear vestibular sensory neuron innervation pattern |
J:84871
|
abnormal type I vestibular cell |
J:84871
|
increased or absent distortion product otoacoustic emission threshold |
J:84871
|
normal
mortality/aging |
J:84871
|
Ntrk2tm1Bbd/Ntrk2tm2Kln Tg(Camk2a-cre)159Kln/0
involves: 129S2/SvPas * CBA/J
|
abnormal avoidance learning behavior |
J:58229
|
abnormal contextual conditioning behavior |
J:58229
|
abnormal learning/memory/conditioning |
J:58229
|
abnormal myelination |
J:58229
|
abnormal spatial learning |
J:58229
|
increased thigmotaxis |
J:58229
|
reduced long-term potentiation |
J:58229
|
Ntrk2tm1Bxu/Ntrk2tm1Bxu
involves: 129 * C57BL/6
|
abnormal dopaminergic neuron morphology |
J:170724
|
abnormal innervation |
J:170724
|
decreased dopaminergic neuron number |
J:170724
|
gliosis |
J:170724
|
increased susceptibility to dopaminergic neuron neurotoxicity |
J:170724
|
normal
mortality/aging |
J:170724
|
neurodegeneration |
J:170724
|
Ntrk2tm1Ddg/Ntrk2tm1Ddg
involves: 129P2/OlaHsd * C57BL/6
|
no abnormal phenotype detected |
J:99603
|
Ntrk2tm1Ddg/Ntrk2tm1Ddg
involves: 129S6/SvEvTac
|
abnormal mammary gland sensory innervation pattern |
J:192549
|
Ntrk2tm1Jom/Ntrk2+ Tg(Syn1-cre)671Jxm/0
involves: 129/Sv * C57BL/6 * ICR
|
decreased kindling response |
J:91467
|
Ntrk2tm1Jom/Ntrk2tm1Jom Tg(GFAP-cre)25Mes/0
involves: FVB/N
|
normal
nervous system phenotype |
J:103935
|
Ntrk2tm1Jom/Ntrk2tm1Jom Tg(Syn1-cre)671Jxm/0
involves: 129/Sv * C57BL/6 * ICR
|
decreased kindling response |
J:91467
|
Ntrk2tm1Kln/Ntrk2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
normal
endocrine/exocrine gland phenotype |
J:210229
|
normal
growth/size/body region phenotype |
J:210229
|
Ntrk2tm1Kln/Ntrk2tm1Kln
involves: 129S1/Sv * 129X1/SvJ
|
abnormal inner ear vestibular sensory neuron innervation pattern |
J:75365,
J:84871
|
abnormal inner ear vestibule morphology |
J:84871
|
abnormal sensory neuron innervation pattern |
J:75365
|
abnormal somatic sensory system morphology |
J:49472,
J:75365
|
abnormal synapse morphology |
J:75365
|
abnormal vestibular nerve morphology |
J:75365
|
abnormal vestibulocochlear nerve morphology |
J:75365
|
absent hair-down neurons |
J:49472
|
decreased sensory neuron number |
J:75365
|
hyperactivity |
J:49472
|
small nodose ganglion |
J:49472
|
small vestibular ganglion |
J:49472
|
Ntrk2tm1Lfp/Ntrk2tm1Lfp
involves: 129
|
abnormal barrel cortex morphology |
J:103935
|
abnormal sensory neuron innervation pattern |
J:103935
|
Ntrk2tm1Lfp/Ntrk2tm1Lfp
involves: 129 * C57
|
abnormal sensory neuron innervation pattern |
J:104489
|
abnormal somatic nervous system morphology |
J:104489
|
postnatal lethality, complete penetrance |
J:104489
|
small cochlear ganglion |
J:104489
|
small geniculate ganglion |
J:104489
|
small nodose ganglion |
J:104489
|
small petrosal ganglion |
J:104489
|
small trigeminal ganglion |
J:104489
|
small vestibular ganglion |
J:104489
|
Ntrk2tm1Lfr/Ntrk2+
involves: 129X1/SvJ
|
abnormal retina ganglion cell morphology |
J:122929
|
Ntrk2tm1Lfr/Ntrk2tm1Lfr
involves: 129X1/SvJ
|
abnormal retina ganglion cell morphology |
J:119332,
J:122929
|
decreased retina ganglion cell number |
J:119332
|
Ntrk2tm1Lfr/Ntrk2tm1Lfr Tg(Camk2a-cre)1Lfr/0
involves: 129X1/SvJ * C57BL/6 * DBA
|
abnormal dendrite morphology |
J:77452
|
abnormal neuron morphology |
J:77452
|
abnormal somatosensory cortex morphology |
J:77452
|
abnormal visual cortex morphology |
J:77452
|
decreased neuron number |
J:77452
|
Ntrk2tm1Mini/Ntrk2+
involves: 129P2/OlaHsd * C57BL/6
|
abnormal liver morphology |
J:210229
|
adrenal cortical hyperplasia |
J:210229
|
normal
behavior/neurological phenotype |
J:210229
|
increased abdominal fat pad weight |
J:210229
|
increased adrenal gland zona fasciculata size |
J:210229
|
increased circulating adrenocorticotropin level |
J:210229
|
increased circulating insulin level |
J:210229
|
increased circulating leptin level |
J:210229
|
increased susceptibility to age related obesity |
J:210229
|
Ntrk2tm1Mini/Ntrk2tm1Mini
involves: 129P2/OlaHsd
|
abnormal excitatory postsynaptic potential |
J:130626
|
abnormal long-term potentiation |
J:130626
|
impaired synaptic plasticity |
J:130626
|
Ntrk2tm1Rohr/Ntrk2+
Not Specified
|
abnormal circulating corticosterone level |
J:179918
|
decreased circulating adrenocorticotropin level |
J:179918
|
decreased circulating corticosterone level |
J:179918
|
decreased circulating follicle stimulating hormone level |
J:88782
|
Ntrk2tm1Rohr/Ntrk2tm1Rohr
involves: ICR
|
abnormal breathing pattern |
J:89227
|
abnormal eyelid morphology |
J:89227
|
abnormal pupillary reflex |
J:89227
|
abnormal retina development |
J:89227
|
abnormal retina rod cell outer segment morphology |
J:89227
|
abnormal rod electrophysiology |
J:89227
|
abnormal vision |
J:89227
|
decreased amacrine cell number |
J:89227
|
decreased body size |
J:89227
|
impaired righting response |
J:89227
|
postnatal lethality, complete penetrance |
J:89227
|
Ntrk2tm1Rohr/Ntrk2tm1Rohr
Not Specified
|
abnormal optic nerve morphology |
J:119332
|
decreased body weight |
J:119332
|
decreased circulating follicle stimulating hormone level |
J:88782
|
decreased granulosa cell proliferation |
J:88782
|
decreased secondary ovarian follicle number |
J:88782
|
impaired granulosa cell differentiation |
J:88782
|
impaired ovarian folliculogenesis |
J:88782
|
postnatal lethality, complete penetrance |
J:119332
|
Ntrk2tm2.1Ddg/Ntrk2tm2.1Ddg
involves: 129P2/OlaHsd
|
abnormal mammary gland sensory innervation pattern |
J:192549
|
Ntrk2tm2.1Ddg/Ntrk2tm2.1Ddg
involves: 129S6/SvEvTac
|
abnormal survival |
J:218012
|
Ntrk2tm2.1Ddg/Ntrk2tm2.1Ddg
involves: 129S6/SvEvTac * C57BL/6
|
neonatal lethality, complete penetrance |
J:196548
|
Ntrk2tm2.1Mini/Ntrk2tm2.1Mini
involves: 129P2/OlaHsd
|
abnormal axon fasciculation |
J:132562
|
abnormal cerebral cortex morphology |
J:132562
|
abnormal neuron differentiation |
J:132562
|
abnormal neuronal migration |
J:132562
|
abnormal vestibular labyrinth morphology |
J:132562
|
astrocytosis |
J:132562
|
postnatal growth retardation |
J:132562
|
postnatal lethality, complete penetrance |
J:132562
|
Ntrk2tm2.1Tes/Ntrk2tm2.1Tes
involves: 129S4/SvJae * C57BL/6J
|
abnormal axon extension |
J:193542
|
abnormal response to novel object |
J:193542
|
abnormal spatial working memory |
J:193542
|
normal
behavior/neurological phenotype |
J:193542
|
normal
nervous system phenotype |
J:193542
|
reduced long-term potentiation |
J:193542
|
Ntrk2tm2Kln/Ntrk2tm2Kln
involves: 129S2/SvPas
|
no abnormal phenotype detected |
J:58229
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Camk2a-cre)159Kln/?
involves: 129S2/SvPas * CBA/J
|
abnormal long-term potentiation |
J:130626
|
impaired synaptic plasticity |
J:130626
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Cck-cre,-lacZ)1Mini/0
involves: 129S2/SvPas * C57BL/6 * CBA
|
abnormal adipose tissue distribution |
J:210229
|
abnormal circadian behavior |
J:210229
|
abnormal circulating corticosterone level |
J:210229
|
abnormal GABAergic neuron physiology |
J:210229
|
abnormal lipid level |
J:210229
|
normal
adipose tissue phenotype |
J:210229
|
adrenal cortical hyperplasia |
J:210229
|
normal
behavior/neurological phenotype |
J:210229
|
hepatic steatosis |
J:210229
|
normal
homeostasis/metabolism phenotype |
J:210229
|
impaired glucose tolerance |
J:210229
|
increased abdominal fat pad weight |
J:210229
|
increased adrenal gland zona fasciculata size |
J:210229
|
increased body weight |
J:210229
|
increased circulating insulin level |
J:210229
|
increased circulating leptin level |
J:210229
|
increased gonadal fat pad weight |
J:210229
|
increased liver weight |
J:210229
|
increased susceptibility to age related obesity |
J:210229
|
increased susceptibility to weight gain |
J:210229
|
increased total body fat amount |
J:210229
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Nes-cre)1Kln/0
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal axon fasciculation |
J:132562
|
abnormal brain morphology |
J:132562
|
abnormal cerebral cortex morphology |
J:132562
|
abnormal cortical plate morphology |
J:132562
|
abnormal myelin sheath morphology |
J:132562
|
abnormal neuron differentiation |
J:132562
|
abnormal neuronal migration |
J:132562
|
abnormal somatosensory cortex morphology |
J:132562
|
abnormal visual cortex morphology |
J:132562
|
demyelination |
J:132562
|
hyperactivity |
J:132562
|
postnatal growth retardation |
J:132562
|
premature death |
J:132562
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Penk-cre,-lacZ)1Mini/0
involves: 129S2/SvPas
|
abnormal gait |
J:204429
|
normal
behavior/neurological phenotype |
J:204429
|
enhanced behavioral response to cocaine |
J:204429
|
increased locomotor activity |
J:204429
|
induced hyperactivity |
J:204429
|
normal
nervous system phenotype |
J:204429
|
Ntrk2tm2Lfp/Ntrk2tm2Lfp Tg(Col2a1-cre)1Bhr/0
involves: 129 * C57BL/6 * SJL
|
decreased birth body size |
J:204227
|
decreased body length |
J:204227
|
decreased body size |
J:204227
|
decreased body weight |
J:204227
|
decreased long bone epiphyseal plate size |
J:204227
|
decreased width of hypertrophic chondrocyte zone |
J:204227
|
kyphosis |
J:204227
|
postnatal growth retardation |
J:204227
|
postnatal lethality, incomplete penetrance |
J:204227
|
Ntrk2tm2Lfr/Ntrk2tm2Lfr Tg(Six3-cre)69Frty/? Tg(Thy1-YFP)HJrs/?
involves: C57BL/6 * CBA * DBA/2
|
abnormal dendrite morphology |
J:122929
|
abnormal retina ganglion cell morphology |
J:122929
|
Ntrk2tm3.1(cre/ERT2)Ddg/Ntrk2tm3.1(cre/ERT2)Ddg
involves: 129S6/SvEvTac * C57BL/6
|
abnormal survival |
J:218012
|
Ntrk2tm4.1Ddg/Ntrk2tm4.1Ddg Aviltm2(cre)Fawa/Avil+
involves: 129P2/OlaHsd * C57BL/6
|
abnormal mammary gland sensory innervation pattern |
J:192549
|